Ubs Group Ag Precipio, Inc. Transaction History

Ubs Group Ag

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 08, 2023	BUY	$0.5 - $17.4 $2,379 - $82,806	4,759 Added 45.04%	15,326 $8,000
Q3 2022 Nov 10, 2022	BUY	$0.78 - $17.8 $6,457 - $147,366	8,279 Added 361.84%	10,567 $9,000
Q2 2022 Aug 10, 2022	SELL	$0.98 - $1.68 $4,857 - $8,327	-4,957 Reduced 68.42%	2,288 $2,000
Q1 2022 May 16, 2022	BUY	$1.19 - $1.71 $4,580 - $6,581	3,849 Added 113.34%	7,245 $10,000
Q4 2021 Feb 14, 2022	SELL	$1.58 - $2.77 $4,000 - $7,013	-2,532 Reduced 42.71%	3,396 $5,000
Q3 2021 Nov 15, 2021	SELL	$2.78 - $3.63 $43,990 - $57,441	-15,824 Reduced 72.75%	5,928 $17,000
Q2 2021 Aug 13, 2021	BUY	$1.8 - $5.25 $38,808 - $113,190	21,560 Added 11229.17%	21,752 $79,000
Q1 2021 May 12, 2021	SELL	$2.1 - $3.89 $18,969 - $35,138	-9,033 Reduced 97.92%	192 $0
Q4 2020 Feb 11, 2021	BUY	$1.94 - $2.64 $17,896 - $24,354	9,225 New	9,225 $19,000
Q3 2020 Nov 12, 2020	SELL	$1.16 - $7.0 $878 - $5,299	-757 Closed	0 $0
Q2 2020 Jul 31, 2020	BUY	$0.58 - $1.51 $439 - $1,143	757 New	757 $1,000
Q4 2019 Feb 14, 2020	SELL	$1.81 - $2.6 $5,945 - $8,541	-3,285 Closed	0 $0
Q3 2019 Nov 14, 2019	BUY	$2.18 - $4.08 $7,161 - $13,402	3,285 New	3,285 $9,000

340

Ticker PRPO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 22,736,500
Market Cap $134M
Description
Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; HemeScreen, a suite of robust geneti...

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

Stay updated on Ubs Group Ag with notifications on news.